ID
27677
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Keywords
Versions (3)
- 11/13/17 11/13/17 -
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 26, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
TNM Staging GSK study Prostatic neoplasms NCT00883909
TNM Staging GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
Description
TNM Staging History
Alias
- UMLS CUI-1
- C3258246
Description
Date of Staging
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0027646
Description
Staging of Prostate Cancer (TNM) (1992)
Data type
text
Alias
- UMLS CUI [1]
- C3260341
Description
Staging of Prostate Cancer (TNM) (1992)
Data type
text
Alias
- UMLS CUI [1,1]
- C1275866
- UMLS CUI [1,2]
- C3846420
Description
Staging of Prostate Cancer (TNM) (1992)
Data type
text
Alias
- UMLS CUI [1]
- C3258247
Similar models
TNM Staging GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
C0750480 (UMLS CUI [1,2])
C0027646 (UMLS CUI [1,2])
C3846420 (UMLS CUI [1,2])
No comments